Bing

SEARCH HISTORY

If the current level of U.S. stock prices is concerning ... health-care exposure through GlaxoSmithKline and AstraZeneca, and consumer-staples exposure through British American Tobacco and spirits maker Diageo. All …
Market Watch · 7/23/2015
stock markets
Health care giant GlaxoSmithKline (NYSE:GSK) is a company shrouded in controversy right now. It is reeling from a bribery scandal in China, and was recently fined $500 million for this. Investors have responded by selling the stock. GlaxoSmithKline is …
Seeking Alpha · 10/31/2014
At Stock Options Channel, our YieldBoost formula has looked up and down the GSK options chain for the new February 2016 contracts and identified one put and one call contract of particular interest. The put contract at the $41.00 strike price has a current ...
Forbes · 6/22/2015
The stock was acquired at an average price of GBX 1,374 ($ ... Velocys, Hiscox, Phoenix, Aviva, GlaxoSmithKline, Rio Tinto, and Hill & Smith. The Company’s investment manager is Henderson Investment Funds Limited. Receive News & Ratings for …
Watch List News · 7/30/2015
Other significant deals include GlaxoSmithKline PLC (NYSE ... in treating this disease than what is currently being demonstrated by its low valuation and stock price. Given the 3.0x or greater revenue multiple valuations for acquisitions in the dermatology ...
SECFilings · 7/21/2015
Clearly GlaxoSmithKline has some challenges to overcome, including the pending loss of a good chunk of its Advair/Seretide revenue a few years from now. Yet, these aforementioned catalysts would suggest that Glaxo's stock has a good shot at soaring in …
The Motley Fool · BySean Williams · 12/16/2014
GSK’s shares jumped 46p, or 3.5pc ... Hossy and Newman mine shafts will result in a significant decrease in unit costs in the long-term. The stock was changing hands at 55.6p by the close – down 3.5p, or 5.9pc. Elsewhere, mounting speculation of ...
Daily Telegraph · 7/29/2015
Premier Farnell
"GSK is one of the last pharmas to really announce its strategy," said Les Funtleyder, portfolio manager with E Squared Asset Management. The company's stock has declined 18 percent in the last 12 months, compared with an increase of 9.6 percent for …
CNBC · 3/11/2015
Thus, buying GlaxoSmithKline means Pfizer would inherit the same problems it's already ... Don't be too late to the party -- click here for one stock to own when the Web goes dark.
Investopedia · 5/22/2015
GlaxoSmithKline took a loss in the fourth quarter of 2010 but the company's stock still managed to climb in trading Thursday. The company announced a stock buyback program that pleases investors, even as the company cuts back on R&D spending for …
Yahoo News · 2/3/2011

GlaxoSmithKline

Company
GlaxoSmithKline plc is a British multinational pharmaceutical company headquartered in Brentford, London. It was the world'…
GlaxoSmithKline plc is a British multinational pharmaceutical company headquartered in Brentford, London. It was the world's sixth-largest pharmaceutical company in 2014, after Pfizer, Novartis, Sanofi, Hoffmann-La Roche and Merck. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham.
Data from: Wikipedia